Poco C85 stands out with its 120Hz display, faster UFS storage, 33W charging, reverse charging support, and higher-resolution cameras. These features make it feel surprisingly advanced for its price.

The past year has been marked by steady smartphone launches, but only a few devices have managed to stay memorable long after the review period. From camera ...

vivo is getting ready to unveil the S50 series next month, and ahead of that the company has today confirmed the S50 Pro mini's chipset - it's the Snapdragon 8 Gen 5, just like a rumor said in late ...

The vivo X300 and X300 Pro launched last month in China, the former with a 6,040 mAh battery, the latter sporting a 6,510 mAh cell. Today there's already a rumor about the X500 series expected next ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

Vivo has confirmed that the Vivo X300 and X300 Pro will launch globally on October 30, with a European debut scheduled for 5 PM that day. The phones, powered by the MediaTek Dimensity 9500 and ...

In 2025, flagship smartphones are more than devices; they’re status symbols and power tools. The Vivo X300 Pro storms in with jaw-dropping specs at a fraction of the price, while the iPhone 17 Pro Max ...

Both it and the cheaper X300 even support the X200 Ultra’s snap-on telephoto extender lens. Both it and the cheaper X300 even support the X200 Ultra’s snap-on telephoto extender lens. is a news editor ...

Editorial Note: Talk Android may contain affiliate links on some articles. If you make a purchase through these links, we will earn a commission at no extra cost to you. Learn more. Vivo officially ...

Chinese smartphone maker Vivo on Thursday unveiled its first mixed reality headset, the "Vivo Vision," and the photocopiers in Dongguan appear to have been working overtime. The device "launched" as ...

Gilead Sciences has become the latest pharma to strengthen its in vivo cell therapy credentials this year, paying $350 million for CAR-T developer Interius BioTherapeutics. Integrating Interius into ...